Trials / Active Not Recruiting
Active Not RecruitingNCT03623074
Control of Myopia Using Novel Spectacle Lens Designs
Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 266 (actual)
- Sponsor
- SightGlass Vision, Inc. · Industry
- Sex
- All
- Age
- 6 Years – 10 Years
- Healthy volunteers
- Accepted
Summary
Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Novel spectacle lens design | Use of lenses may reduce the rate of progression of juvenile myopia |
| DEVICE | Spectacle lenses | Use of lenses may reduce the rate of progression of juvenile myopia |
Timeline
- Start date
- 2018-07-16
- Primary completion
- 2022-05-15
- Completion
- 2026-03-31
- First posted
- 2018-08-09
- Last updated
- 2024-12-20
Locations
14 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03623074. Inclusion in this directory is not an endorsement.